KLF4 defines the efficacy of the epidermal growth factor receptor inhibitor, erlotinib, in triple-negative breast cancer cells by repressing the EGFR gene by Roberts, Melyssa S, Anstine, Lindsey J, Finke, Viviane S, Bryson, Benjamin L, Webb, Bryan M, Weber-Bonk, Kristen L, Seachrist, Darcie D, Majmudar, Parth R, Keri, Ruth A

Get full text

Disruption of CDK7 signaling leads to catastrophic chromosomal instability coupled with a loss of condensin-mediated chromatin compaction by Piemonte, Katrina M., Webb, Bryan M., Bobbitt, Jessica R., Majmudar, Parth R., Cuellar-Vite, Leslie, Bryson, Benjamin L., Latina, Nicholas C., Seachrist, Darcie D., Keri, Ruth A.

Get full text

TLE3 Sustains Luminal Breast Cancer Lineage Fidelity to Suppress Metastasis by Anstine, Lindsey J, Majmudar, Parth R, Aponte, Amy, Singh, Salendra, Zhao, Ran, Weber-Bonk, Kristen L, Abdul-Karim, Fadi W, Valentine, Mitchell, Seachrist, Darcie D, Grennel-Nickelson, Katelyn E, Cuellar-Vite, Leslie, Sizemore, Gina M, Sizemore, Steven T, Webb, Bryan M, Thompson, Cheryl L, Keri, Ruth A

Get full text

Differences in Endothelin B Receptor Isoforms Expression and Function in Breast Cancer Cells by Halaka, Meena, Hired, Zuhaila A, Rutledge, Grace E, Hedgepath, Carly M, Anderson, Michael P, St John, Haley, Do, Jessica M, Majmudar, Parth R, Walker, Caleb, Alawawdeh, Asma, Stephen, Hannah M, Reagor, Caleb C, Adereti, Jeanette, Jamison, Kiara, Iglesias, Katherine P, Kirmani, Khadija Z, Conway, Rebecca E

Get full text